Ftse Mib
34.888,79
0,09%
DAX
20.405,92
-0,11%
S&P 500
6.051,09
0,00%
NASDAQ
19.926,72
0,12%
Bitcoin
101.762,94
0,31%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Hikma Pharmaceuticals Plc (HIK) Hikma Pharmaceuticals Plc (HIK) Notizie

HIK

Hikma Pharmaceuticals (HIK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HIK
DataOraFonteTitoloSimboloCompagnia
07/11/202416:30RNS Regulatory NewsHikma Pharmaceuticals Plc Outcome of Audit Tender ProcessLSE:HIKHikma Pharmaceuticals Plc
07/11/202411:59Alliance NewsAlliance NewsHikma Pharmaceuticals reiterates full-year guidance amid strong growthLSE:HIKHikma Pharmaceuticals Plc
07/11/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
24/10/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc 2024 Annual General Meeting Update StatementLSE:HIKHikma Pharmaceuticals Plc
01/10/202410:45RNS Regulatory NewsHikma Pharmaceuticals Plc Block listing Interim ReviewLSE:HIKHikma Pharmaceuticals Plc
24/09/202411:09RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
10/09/202410:09Alliance NewsAlliance NewsHikma Pharmaceuticals completes acquisition of Xellia's FDF businessLSE:HIKHikma Pharmaceuticals Plc
10/09/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma completes Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
03/09/202413:46Alliance NewsAlliance NewsIN THE KNOW: Berenberg sees "standout" year at Hikma's Injectibles armLSE:HIKHikma Pharmaceuticals Plc
20/08/202418:15PR Newswire (US)Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention DayLSE:HIKHikma Pharmaceuticals Plc
15/08/202421:18PR Newswire (US)KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 monthsLSE:HIKHikma Pharmaceuticals Plc
13/08/202411:16Alliance NewsAlliance NewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 sharesLSE:HIKHikma Pharmaceuticals Plc
08/08/202412:33Alliance NewsAlliance NewsHikma Pharmaceuticals raises guidance as first-half profit jumps 43%LSE:HIKHikma Pharmaceuticals Plc
08/08/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc Half-year ReportLSE:HIKHikma Pharmaceuticals Plc
29/07/202417:08RNS Regulatory NewsHikma Pharmaceuticals Plc Director DeclarationLSE:HIKHikma Pharmaceuticals Plc
15/07/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc Notice of ResultsLSE:HIKHikma Pharmaceuticals Plc
01/07/202415:47RNS Regulatory NewsHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
17/06/202410:14Alliance NewsAlliance NewsHikma adds scale to US injectables business with Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
17/06/202408:00RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma acquires Xellia’s assetsLSE:HIKHikma Pharmaceuticals Plc
11/06/202414:05Alliance NewsAlliance NewsIN THE KNOW: Citi lifts Hikma price target amid positive industry dataLSE:HIKHikma Pharmaceuticals Plc
25/04/202415:28RNS Regulatory NewsHikma Pharmaceuticals Plc Result of AGMLSE:HIKHikma Pharmaceuticals Plc
25/04/202411:15Alliance NewsAlliance NewsHikma Pharmaceuticals backs outlook after making strong start to 2024LSE:HIKHikma Pharmaceuticals Plc
15/04/202417:43RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma appoints new President of Generics businessLSE:HIKHikma Pharmaceuticals Plc
22/03/202410:21RNS Regulatory NewsHikma Pharmaceuticals Plc Annual Financial Report and Notice of AGMLSE:HIKHikma Pharmaceuticals Plc
22/02/202410:42Alliance NewsAlliance NewsTOP NEWS: Hikma boosts dividend after year of "significant progress"LSE:HIKHikma Pharmaceuticals Plc
22/02/202408:09Alliance NewsAlliance News*Hikma Pharmaceuticals says core operating profit to be in range of USD660m to USD700mLSE:HIKHikma Pharmaceuticals Plc
22/02/202408:08Alliance NewsAlliance News*Hikma Pharmaceuticals expect revenue to grow in the range of 4% to 6%LSE:HIKHikma Pharmaceuticals Plc
22/02/202408:08Alliance NewsAlliance News*Hikma Pharmaceuticals confident that strategy will continue to deliver growth in 2024LSE:HIKHikma Pharmaceuticals Plc
22/02/202408:07Alliance NewsAlliance News*Hikma Pharmaceuticals declares FY dividend of 73 US cents per share vs 56 cents YoYLSE:HIKHikma Pharmaceuticals Plc
22/02/202408:06Alliance NewsAlliance News*Hikma Pharmaceuticals 2023 pretax profit USD520m vs USD233m YoYLSE:HIKHikma Pharmaceuticals Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HIK

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
TIT
Telecom Italia
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
STMMI
ST Microelectronics
BIT
IVG
Iveco Group NV
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network